Skip to main content
Erschienen in: Journal of Ophthalmic Inflammation and Infection 1/2016

Open Access 01.12.2016 | Letter to the Editor

Reply to “Early resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt-Koyanagi Harada disease” by Sugita et al.

verfasst von: Kalpana Babu, Aditi Parikh

Erschienen in: Journal of Ophthalmic Inflammation and Infection | Ausgabe 1/2016

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

We read with great interest the article by Sugita et al. on early resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt-Koyanagi-Harada disease. We would like to share a similar experience where the subretinal fluid resolved within 2 weeks without treatment in a pregnant woman who was in her second trimester.
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

Dr. KB conceived and designed this study and was involved in acquisition, analysis, and interpretation of data. Dr. AP was involved in the acquisition of the data and drafting of the manuscript. All authors have read and approved the final manuscript.
Abkürzungen
BCVA
best corrected visual acuity
BP
blood pressure
OD
right
OS
left
OU
both
VKH
Vogt-Koyanagi Harada disease
Dear editor,
We read with great interest the brief report by Sugita et al. [1] regarding “Early resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt-Koyanagi-Harada disease.” We would like to share a similar case who presented to our clinic recently. A 31-year-old woman in the second trimester of pregnancy (24 weeks) presented with sudden blurring of vision in both eyes of 2 days duration. She had a vague history of headache. Her BCVA was 20/120 and 20/200 in OD and OS, respectively. Slitlamp examination was normal. Fundus examination showed occasional vitreous cells and bilateral, multifocal serous retinal detachments (Fig. 1a, b). Intraocular pressures were normal. OCT confirmed the foveal neurosensory detachments (Fig. 2a, b). Choroidal thickness was 1.6 and 1.8 mm in OD and OS, respectively. Fluorescein angiography was not done in view of the pregnancy. Her BP was 120/70 mm of Hg. Routine laboratory investigations to rule out other causes of uveitis did not reveal any abnormality. She had no history of any systemic disease. Based on the clinical findings, she was diagnosed to have incomplete VKH and was recommended systemic corticosteroids. However, the patient refused treatment because she was worried about adverse effects to the fetus. She came to us 2 weeks later with a dramatic improvement in her symptoms and ocular signs. Her BCVA was now 20/30 (OU). Early depigmentary alterations were now seen in the retinal periphery (Fig. 3ac). She was lost to follow-up thereafter. We learnt from her treating obstetrician, she had delivered a healthy male baby 3 months later. What is interesting is the occurrence of inflammation in the second trimester of pregnancy and the rapid resolution of fluid within 2 weeks without treatment, in a patient without a prior history of VKH. However, unlike the case by Sugita et al. [1], our patient did not have any systemic disease and did not receive any corticosteroids in the past. Though it is difficult to explain the observation seen, this case in addition to the case reported by Sugita et al. [1] has shown early resolution of subretinal fluid without treatment in VKH leading us to revisit the role of pregnancy in VKH.

Acknowledgements

None.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

Dr. KB conceived and designed this study and was involved in acquisition, analysis, and interpretation of data. Dr. AP was involved in the acquisition of the data and drafting of the manuscript. All authors have read and approved the final manuscript.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Sugiita K, Mizumuto K, Kato N et al (2015) Early resolution of subretinal fluid without high dose corticosteroids in a pregnant patient with Vogt-Koyanagi Harada disease: a case report. J Ophthalmic Inflamm Infect 5:20CrossRef Sugiita K, Mizumuto K, Kato N et al (2015) Early resolution of subretinal fluid without high dose corticosteroids in a pregnant patient with Vogt-Koyanagi Harada disease: a case report. J Ophthalmic Inflamm Infect 5:20CrossRef
Metadaten
Titel
Reply to “Early resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt-Koyanagi Harada disease” by Sugita et al.
verfasst von
Kalpana Babu
Aditi Parikh
Publikationsdatum
01.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Ophthalmic Inflammation and Infection / Ausgabe 1/2016
Elektronische ISSN: 1869-5760
DOI
https://doi.org/10.1186/s12348-016-0080-5

Weitere Artikel der Ausgabe 1/2016

Journal of Ophthalmic Inflammation and Infection 1/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.